rss
Br J Ophthalmol 81:599-607 doi:10.1136/bjo.81.7.599
  • Perspective

Use of isolated ocular arteries in vitro to define the pathology of vascular changes in glaucoma

Table 3

Responses of ocular arteries to constrictor agonists

Agonist Artery Species Receptor Mechanisms
Noradrenaline Ophthalmic: porcine, canine, feline α1
Ciliary: human
bovine, canine α1
Adrenaline Ophthalmic: canine, feline
Ciliary: human, canine
Retinal: porcine
Phenylephrine Ophthalmic: canine, feline α1
Ciliary: human, canine α1
Retinal: bovine α1
α2Agonists Ophthalmic: canine, feline No contraction
Ciliary: human, canine No contraction
5-HT Ophthalmic: human, feline
porcine 5-HT2
rabbit 5-HT1/2
Ciliary: human
porcine, bovine 5-HT2
Retinal: bovine
Histamine Ophthalmic: feline
Ciliary: human
bovine H1
Angiotensin II Ciliary: human, bovine
porcine AT1
Retinal: bovine No contraction
feline AT1
Endothelin-1 Ophthalmic: human PLC activation?
porcine
Ciliary: porcine Influx extracellular Ca2+
Retinal: bovine Influx extracellular Ca2+
PGF Ophthalmic: porcine, canine
Ciliary: porcine, bovine, canine
Retinal: bovine
PGD2 Ophthalmic: canine
PGE2 Retinal: bovine
TxA2/U46619 Ophthalmic: canine
Ciliary: porcine
Retinal: bovine
  • α Adrenoceptor (α12), 5-hydroxytryptamine (5-HT), 5-HT receptors (5-HT1/2), histamine receptor (H1), angiotensin II receptor (AT1), phospholipase C (PLC), prostaglandins (PG), thromboxane A2 (TxA2).

This Article

Register for free content


Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of BJO.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.